Aberrations and in good shape sufficient to tolerate FCR therapy, may still be very good candidates for your latter, with the advantage getting that this therapy is usually concluded in six months even though ibrutinib need to be taken indefinitely. Are BTK and PLCG2 mutations important and enough for ibrutinib https://situs-judi-mbl7785185.articlesblogger.com/55681183/the-basic-principles-of-situs-judi-mbl77